Multimorbidity: a global public health challenge
Multimorbidity
Abstract
According to available data, at least 50 million people in the European Union live with multimorbidity. The trend of an aging population, accompanied by the adoption of unhealthy lifestyles and the rising incidence of chronic illnesses, results in a increase in the occurrence of multimorbidity.This trend has proved to be a major challenge for healthcare systems worldwide. To effectively address the strain on healthcare systems caused by multimorbidity, it is imperative to prioritize the establishment of well-structured, adequately equipped, and appropriately trained primary care teams. Healthcare should be proactive and include a preventive component for patients at risk of multimorbidity. Furthermore, primary healthcare should establish a network with other levels in the healthcare system, including the system of education and social protection programs. This integration should extend to the entire local community, aiming to enhance the well-being of both the individual and the community as a whole. Multimorbidity has show to be a significant obstacle for healthcare systems worldwide, making a need for guidance among health policy makers, health managers and physicians in defining and implementing interventions aimed at decreasing the burden associated with multimorbidity.
References
1. Eurostat. (2022a). Life expectancy across EU regions in 2020 [WWW document]. Eurostat news. Dostupno na: https://ec.europa.eu/eurostat/web/products-eurostat-news/-/ddn-20220427-1.
2. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37-43.
3. The Academy of Medical Sciences. Multimorbidity: a priority for global health research. Academy of Medical Sciences, 2018. Available at: https://acmedsci.ac.uk/filedownload/82222577
4. Rijken M, Struckmann V, Dyakova M, Gabriella Melchiorre M, Rissanen S, van Ginneken E. ICARE4EU: improving care for people with multiple chronic conditions in Europe. Eurohealth 2013;19(3):29–31.
5. Menotti A, et al. Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol. 2001; 54: 680–686.
6. Wei MY, Mukamal KJ. Multimorbidity, mortality, and long-term physical functioning in 3 prospective cohorts of community-dwelling adults. Am J Epidemiol. (2018) 187:103–12.
7. Mavaddat N, Valderas JM, van der Linde R, Khaw KT, Kinmonth AL. Association of self-rated health with multimorbidity, chronic disease and psychosocial factors in a large middle-aged and older cohort from general practice: a cross-sectional study. BMC Fam Pract. (2014) 15:185.
8. Stirland LE, González-Saavedra L, Mullin DS, Ritchie CW, Muniz-Terrera G, Russ TC. Measuring multimorbidity beyond counting diseases: systematic review of community and population studies and guide to index choice. BMJ. 2020 Feb 18;368:m160.
9. Ho IS, Azcoaga-Lorenzo A, Akbari A, Black C, Davies J, Hodgins P, Khunti K, Kadam U, Lyons RA, McCowan C, Mercer S, Nirantharakumar K, Guthrie B. Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies. Lancet Public Health. 2021 Aug;6(8):e587-e597.
10. Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, Boyd CM, Pati S, Mtenga S, Smith SM. Multimorbidity. Nat Rev Dis Primers. 2022 Jul 14;8(1):48.
11. Fortin M, Stewart M, Poitras M-E, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012; 10: 142–151.
12. Uijen AA, van de Lisdonk EH. Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract. 2008;14(s1):28-32.
13. Nguyen H, Manolova G, Daskalopoulou C, Vitoratou S, Prince M, Prina AM. Prevalence of multimorbidity in community settings: a systematic review and meta-analysis of observational studies. J Comorb. (2019) 9:1–15.
14. Asogwa, O.A.; Boateng, D.; Marzà-Florensa, A.; Peters, S.; Levitt, N.; van Olmen, J.; Klipstein-Grobusch, K. Multimorbidity of non-communicable diseases in low-income and middle-income countries: A systematic review and meta-analysis. BMJ Open 2022, 12, e49133.
15. Hu, X.; Huang, J.; Lv, Y.; Li, G.; Peng, X. Status of prevalence study on multimorbidity of chronic disease in China: Systematic review. Geriatr. Gerontol. Int. 2014, 15, 1–10.
16. Vos T, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). 2020; 396: 1204–1222.
17. Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PloS One. 2014;9(7):e102149.
18. Schafer I, Hansen H, Schon G, Hofels S, Altiner A, Dahlhaus A, et al. The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. First results from the multicare cohort study. BMC Health Ser Res. 2012;12:89.
19. Garin, N.; Koyanagi, A.; Chatterji, S.; Tyrovolas, S.; Olaya, B.; Leonardi, M.; Lara, E.; Koskinen, S.; Tobiasz-Adamczyk, B.; Ayuso-Mateos, J.L.; et al. Global Multimorbidity Patterns: A Cross-Sectional, Population-Based, Multi-Country Study. J. Gerontol. Ser. A 2016, 71, 205–214.
20. Ahmadi, B.; Alimohammadian, M.; Yaseri, M.; Majidi, A.; Boreiri, M.; Islami, F.; Poustchi, H.; Derakhshan, M.H.; Feizesani, A.; Pourshams, A.; et al. Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis. Medicine 2016, 95, e2756.
21. Vancampfort, D.; Smith, L.; Stubbs, B.; Swinnen, N.; Firth, J.; Schuch, F.B.; Koyanagi, A. Associations between active travel and physical multi- morbidity in six low- and middle-income countries among community- dwelling older adults: A cross-sectional study. PLoS ONE 2018, 13, e203277.
22. McLean G, Gunn J, Wyke S, Guthrie B, Watt GC, Blane DN, et al. The influence of socioeconomic deprivation on multimorbidity at different ages: a cross-sectional study. Br J Gen Pract. 2014;64(624):e440-7.
23. Arokiasamy, P.; Uttamacharya, U.; Jain, K.; Biritwum, R.B.; Yawson, A.E.; Wu, F.; Guo, Y.; Maximova, T.; Espinoza, B.M.; Rodríguez, A.S.; et al. The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: What does the study on global ageing and adult health (SAGE) reveal? BMC Med. 2015, 13, 178.
24. Pathirana TI, Jackson CA. Socioeconomic Status and Multimorbidity: a Systematic Review and Meta-analysis. Aust N Z J Public Health (2018) 2(2):186–94.
25. Seo S, Kwon YD, Yoo K-B, Lee Y, Noh J-W. Is Transient and Persistent Poverty Harmful to Multimorbidity?: Model Testing Algorithms. Int J Environ Res Public Health (2019) 16(13):2395.
26. Hernández B, Voll S, Lewis NA, McCrory C, White A, Stirland L, et al. Comparisons of Disease Cluster Patterns, Prevalence and Health Factors in the USA, Canada, England and Ireland. BMC Public Health (2021) 21(1):1674–15.
27. Singer L, Green M, Rowe F, Ben-Shlomo Y, Kulu H, Morrissey K. Trends in Multimorbidity, Complex Multimorbidity and Multiple Functional Limitations in the Ageing Population of England, 2002-2015. J Comorb (2002–20152019) 9:2235042X19872030.
28. Kunna R, San Sebastian M, Stewart Williams J. Measurement and Decomposition of Socioeconomic Inequality in Single and Multimorbidity in Older Adults in China and Ghana: Results from the WHO Study on Global AGEing and Adult Health (SAGE). Int J Equity Health (2017) 16(1):79–17.
29. Miranda JJ, et al. Understanding the rise of cardiometabolic diseases in low-and middle-income countries. Nat Med. 2019; 25: 1667–1679.
30. Pesantes MA, Tetens A, Valle AD, Miranda JJ. “It is Not Easy Living with This Illness”: A Syndemic Approach to Medication Adherence and Lifestyle Change among Low-income Diabetes Patients in Lima, Peru. Hum Org. 2019; 78: 85–96.
31. Jan S, et al. Action to address the household economic burden of non-communicable diseases. Lancet (London, England). 2018; 391: 2047–2058.
32. Macinko J, Andrade FCD, Nunes BP, Guanais FC. Primary care and multimorbidity in six Latin American and Caribbean countries. Rev Panam Salud Publica. 2019; 43 e8
33. Aebischer Perone S, et al. Report of the WHO independent high-level commission on NCDs: where is the focus on addressing inequalities? BMJ Glob Health. 2020; 5.
34. Multimorbidity: Technical Series on Safer Primary Care. Geneva: World Health Organization; 2016. Licence: CC BY-NC-SA 3.0 IGO. Dostupno na: https://apps.who.int/iris/bitstream/handle/10665/252275/9789241511650-eng.pdf?sequence=1
35. Boyd CM, Kent DM. Evidence-based medicine and the hard problem of multimorbidity. J Gen Intern Med. 2014; 29: 552–553.
36. Hargraves IG, Montori VM. Aligning care with patient values and priorities. JAMA Intern Med. 2019; 179: 1697–1698.
37. Lehnert T, et al. Review: health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev. 2011; 68: 387–420.
38. Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol. 2012; 65: 1041–1051.
39. May CR, et al. Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health Serv Res. 2014; 14: 1–11.
40. Chikumbu E, et al. Experiences of multimorbidity in urban and rural Malawi: An interview study of burdens of treatment and lack of treatment. PLOS Glob Public Health. 2022; 2 e0000139.
41. Kruk ME, et al. High-quality health systems in the Sustainable Development Goals era: time for a revolution. The Lancet Global Health. 2018; 6: e1196–e1252.
42. Glynn LG, Valderas JM, Healy P, Burke E, Newell J, Gillespie P, et al. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011;28(5):516-23.
43. Roland M, Paddison C. Better management of patients with multimorbidity. BMJ. 2013;346:f2510.
44. Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, Boyd CM, Pati S, Mtenga S, Smith SM. Multimorbidity. Nat Rev Dis Primers. 2022 Jul 14;8(1):48.